Concentrix (CNXC) Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Concentrix in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNXC shares.
View CNXC analyst ratings or view top-rated stocks.

5 equities research analysts have issued 1-year price targets for Concentrix's stock. Their CNXC share price forecasts range from $70.00 to $165.00. On average, they expect the company's stock price to reach $120.60 in the next twelve months. This suggests a possible upside of 54.0% from the stock's current price.
View analysts price targets for CNXC or view top-rated stocks among Wall Street analysts.

Concentrix's stock was trading at $133.16 at the beginning of 2023. Since then, CNXC shares have decreased by 41.2% and is now trading at $78.30.
View the best growth stocks for 2023 here.

Concentrix saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,820,000 shares, an increase of 7.1% from the August 31st total of 1,700,000 shares. Based on an average trading volume of 404,600 shares, the days-to-cover ratio is presently 4.5 days. Currently, 4.2% of the company's shares are short sold.
View Concentrix's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, January 18th 2024.
View our CNXC earnings forecast.

Concentrix Co. (NASDAQ:CNXC) posted its quarterly earnings data on Wednesday, June, 28th. The company reported $2.69 earnings per share for the quarter, missing analysts' consensus estimates of $2.75 by $0.06. The firm earned $1.61 billion during the quarter, compared to analyst estimates of $1.66 billion. Concentrix had a trailing twelve-month return on equity of 19.04% and a net margin of 5.35%. The business's quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.74 earnings per share.

Concentrix declared a quarterly dividend on Wednesday, September 27th. Stockholders of record on Friday, October 27th will be paid a dividend of $0.303 per share on Tuesday, November 7th. This represents a $1.21 annualized dividend and a yield of 1.55%. The ex-dividend date is Thursday, October 26th. This is an increase from the stock's previous quarterly dividend of $0.28.
Read our dividend analysis for CNXC.

ETFs with the largest weight of Concentrix (NASDAQ:CNXC) stock in their portfolio include Invesco S&P Spin-Off ETF (CSD), First Trust Technology AlphaDEX Fund (FXL), Thrivent Small-Mid Cap ESG ETF (TSME), First Trust Mid Cap Value AlphaDEX Fund (FNK) and Nuveen ESG Small-Cap ETF (NUSC).Pacer US Cash Cows Growth ETF (BUL).

Concentrix (NASDAQ:CNXC) pays an annual dividend of $1.10 per share and currently has a dividend yield of 1.37%. The dividend payout ratio is 16.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNXC will have a dividend payout ratio of 9.46% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNXC.

Concentrix issued an update on its fourth quarter 2023 earnings guidance on Wednesday, September, 27th. The company provided earnings per share (EPS) guidance of $3.03-$3.15 for the period, compared to the consensus EPS estimate of $3.32. The company issued revenue guidance of $2.19 billion-$2.21 billion, compared to the consensus revenue estimate of $1.70 billion.

(CNXC) raised $75 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 5,000,000 shares at a price of $15.00 per share. BofA Merrill Lynch, Wells Fargo Securities, Citigroup, Jefferies, Scotia Howard Weil, Credit Suisse, J.P. Morgan, Evercore ISI, BB&T Capital Markets, Goldman, Sachs, The Huntington Investment Company, Stifel and Nomura acted as the underwriters for the IPO and Clarksons Platou Securities, Cowen and Company and Tuohy Brothers were co-managers.

Concentrix trades on the NASDAQ under the ticker symbol "CNXC."

Shares of CNXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CNXC stock can currently be purchased for approximately $78.30.

Concentrix (NASDAQ:CNXC) has a market capitalization of $4.08 billion and generates $6.32 billion in revenue each year. The company earns $435.05 million in net income (profit) each year or $6.69 on an earnings per share basis.

The company employs 315,000 workers across the globe.

The official website for the company is www.concentrix.com. The company can be reached via phone at 800-747-0583 or via email at david.stein@concentrix.com.